248 related articles for article (PubMed ID: 30206369)
1. A randomised phase II trial of S-1 plus cisplatin versus vinorelbine plus cisplatin with concurrent thoracic radiotherapy for unresectable, locally advanced non-small cell lung cancer: WJOG5008L.
Sasaki T; Seto T; Yamanaka T; Kunitake N; Shimizu J; Kodaira T; Nishio M; Kozuka T; Takahashi T; Harada H; Yoshimura N; Tsutsumi S; Kitajima H; Kataoka M; Ichinose Y; Nakagawa K; Nishimura Y; Yamamoto N; Nakanishi Y
Br J Cancer; 2018 Sep; 119(6):675-682. PubMed ID: 30206369
[TBL] [Abstract][Full Text] [Related]
2. Randomized phase II trial of S-1 plus cisplatin or docetaxel plus cisplatin with concurrent thoracic radiotherapy for inoperable stage III non-small cell lung cancer.
Shimokawa T; Yamada K; Tanaka H; Kubota K; Takiguchi Y; Kishi K; Saito H; Hosomi Y; Kato T; Harada D; Otani S; Kasai T; Nakamura Y; Misumi T; Yamanaka T; Okamoto H
Cancer Med; 2021 Jan; 10(2):626-633. PubMed ID: 33319495
[TBL] [Abstract][Full Text] [Related]
3. S-1 plus cisplatin with concurrent radiotherapy for locally advanced non-small cell lung cancer: a multi-institutional phase II trial (West Japan Thoracic Oncology Group 3706).
Ichinose Y; Seto T; Sasaki T; Yamanaka T; Okamoto I; Takeda K; Tanaka M; Katakami N; Sawa T; Kudoh S; Saka H; Nishimura Y; Nakagawa K; Fukuoka M
J Thorac Oncol; 2011 Dec; 6(12):2069-75. PubMed ID: 22052226
[TBL] [Abstract][Full Text] [Related]
4. Long-term results of S-1 plus cisplatin with concurrent thoracic radiotherapy for locally advanced non-small-cell lung cancer.
Taira T; Yoh K; Nagase S; Kubota K; Ohmatsu H; Niho S; Onozawa M; Akimoto T; Ohe Y; Goto K
Cancer Chemother Pharmacol; 2018 Mar; 81(3):565-572. PubMed ID: 29387962
[TBL] [Abstract][Full Text] [Related]
5. Concurrent chemoradiotherapy with cisplatin and S-1 or vinorelbine for patients with stage III unresectable non-small cell lung cancer: A retrospective study.
Takase N; Hattori Y; Kiriu T; Itoh S; Kawa Y; Yamamoto M; Urata Y; Shimada T; Tsujino K; Soejima T; Negoro S; Satouchi M
Respir Investig; 2016 Sep; 54(5):334-40. PubMed ID: 27566381
[TBL] [Abstract][Full Text] [Related]
6. A randomized phase II study of S-1 monotherapy versus cisplatin with vinorelbine for completely resected stage II/IIIA non-small cell lung cancer: rationale and study protocol design for the LOGIK1702 study.
Tsuchiya T; Matsumoto K; Miyazaki T; Doi R; Tokunaga S; Yamaguchi H; Tomoshige K; Watanabe H; Nagayasu T; Sugio K
BMC Cancer; 2021 Mar; 21(1):249. PubMed ID: 33685421
[TBL] [Abstract][Full Text] [Related]
7. A phase II study of cisplatin plus S-1 with concurrent thoracic radiotherapy for locally advanced non-small-cell lung cancer: the Okayama Lung Cancer Study Group Trial 0501.
Nogami N; Takigawa N; Hotta K; Segawa Y; Kato Y; Kozuki T; Oze I; Kishino D; Aoe K; Ueoka H; Kuyama S; Harita S; Okada T; Hosokawa S; Inoue K; Gemba K; Shibayama T; Tabata M; Takemoto M; Kanazawa S; Tanimoto M; Kiura K
Lung Cancer; 2015 Feb; 87(2):141-7. PubMed ID: 25534129
[TBL] [Abstract][Full Text] [Related]
8. Comparison of vinorelbine plus cisplatin and S-1 plus cisplatin in concurrent chemoradiotherapeutic regimens for unresectable stage III non-small cell lung cancer.
Shukuya T; Takahashi T; Harada H; Akamatsu H; Sakaguchi C; Imai H; Ono A; Nakamura Y; Tsuya A; Kenmotsu H; Naito T; Murakami H; Endo M; Takahashi K; Yamamoto N
Anticancer Res; 2012 Feb; 32(2):675-80. PubMed ID: 22287762
[TBL] [Abstract][Full Text] [Related]
9. Concurrent chemoradiation for locally advanced stage III non-small cell lung cancer with cisplatin, vinorelbine, and thoracic radiotherapy: a phase II study from the Galician Lung Cancer Group.
Costa Rivas M; Huidobro Vence G; Fírvida Pérez JL; Campos Balea B; García Gonzalez J; Lázaro Quintela M; Caeiro Muñoz M; Taboada Valladares B; Castro Gómez JE; Vázquez Estevez S; Afonso Afonso FJ; Azpitarte Raposeiras C; Amenedo Gancedo M; Casal Rubio J
Clin Transl Oncol; 2018 Nov; 20(11):1467-1473. PubMed ID: 29696478
[TBL] [Abstract][Full Text] [Related]
10. Induction chemotherapy with cetuximab, vinorelbine-cisplatin followed by thoracic radiotherapy and concurrent cetuximab, vinorelbine-cisplatin in patients with unresectable stage III non-small cell lung cancer.
Liu D; Zheng X; Chen J; Liu G; Xu Y; Shen Y; Xie L; Zhao W; Jiang G; Fan M
Lung Cancer; 2015 Sep; 89(3):249-54. PubMed ID: 26118463
[TBL] [Abstract][Full Text] [Related]
11. Preoperative chemoradiotherapy using cisplatin plus S-1 can induce downstaging in patients with locally advanced (stage III) non-small-cell lung cancer.
Kato M; Onishi H; Matsumoto K; Tsuruta N; Higuchi K; Motoshita J; Katano M
Anticancer Res; 2012 Nov; 32(11):5099-104. PubMed ID: 23155287
[TBL] [Abstract][Full Text] [Related]
12. Randomized phase II study of chemoradiotherapy with cisplatin + S-1 versus cisplatin + pemetrexed for locally advanced non-squamous non-small cell lung cancer: SPECTRA study.
Niho S; Yoshida T; Akimoto T; Sakamaki K; Ono A; Seto T; Nishio M; Yamamoto N; Hida T; Okamoto H; Kurata T; Satouchi M; Goto K; Yamanaka T; Ohe Y
Lung Cancer; 2020 Mar; 141():64-71. PubMed ID: 31955002
[TBL] [Abstract][Full Text] [Related]
13. Randomized phase II trial of uracil/tegafur and cisplatin versus vinorelbine and cisplatin with concurrent thoracic radiotherapy for locally advanced unresectable stage III non-small-cell lung cancer: NJLCG 0601.
Sugawara S; Maemondo M; Tachihara M; Inoue A; Ishimoto O; Sakakibara T; Usui K; Watanabe H; Matsubara N; Watanabe K; Kanazawa K; Ishida T; Saijo Y; Nukiwa T;
Lung Cancer; 2013 Jul; 81(1):91-6. PubMed ID: 23643176
[TBL] [Abstract][Full Text] [Related]
14. A multi-institutional phase II trial of consolidation S-1 after concurrent chemoradiotherapy with cisplatin and vinorelbine for locally advanced non-small cell lung cancer.
Kawaguchi T; Takada M; Ando M; Okishio K; Atagi S; Fujita Y; Tomizawa Y; Hayashihara K; Okano Y; Takahashi F; Saito R; Matsumura A; Tamura A
Eur J Cancer; 2012 Mar; 48(5):672-7. PubMed ID: 22172569
[TBL] [Abstract][Full Text] [Related]
15. Phase II study of oral S-1 and cisplatin with concurrent radiotherapy for locally advanced non-small-cell lung cancer.
Kaira K; Tomizawa Y; Yoshino R; Yoshii A; Matsuura M; Iwasaki Y; Koga Y; Ono A; Nishioka M; Kamide Y; Hisada T; Ishizuka T; Shirai K; Ebara T; Saitoh J; Nakano T; Sunaga N
Lung Cancer; 2013 Dec; 82(3):449-54. PubMed ID: 24099666
[TBL] [Abstract][Full Text] [Related]
16. Phase III study of cisplatin with pemtrexed or vinorelbine plus concurrent late course accelerated hyperfractionated radiotherapy in patients with unresectable stage III non-small cell lung cancer.
Zhao Q; Wang Z; Huang W; Wang Q; Yu S; Zhou T; Han D; Wu Z; Gong H; Sun H; Zhang J; Wei Y; Li H; Zhang Z; Lin H; Li B
Oncotarget; 2016 Feb; 7(7):8422-31. PubMed ID: 26761213
[TBL] [Abstract][Full Text] [Related]
17. S-1 plus cisplatin with concurrent radiotherapy versus cisplatin alone with concurrent radiotherapy for stage III non-small cell lung cancer: a pilot randomized controlled trial.
Yao L; Xu S; Xu J; Yang C; Wang J; Sun D
Radiat Oncol; 2015 Jan; 10():10. PubMed ID: 25572571
[TBL] [Abstract][Full Text] [Related]
18. Oral vinorelbine-based concomitant chemoradiotherapy in unresectable stage III non-small cell lung cancer: a systematic review.
Lesueur P; Martel-Laffay I; Escande A; Kissel M; Locher C; Gervais R; Schott R; Vergnenegre A; Chouaid C
Expert Rev Anticancer Ther; 2018 Nov; 18(11):1159-1165. PubMed ID: 30173589
[TBL] [Abstract][Full Text] [Related]
19. GILT--A randomised phase III study of oral vinorelbine and cisplatin with concomitant radiotherapy followed by either consolidation therapy with oral vinorelbine and cisplatin or best supportive care alone in stage III non-small cell lung cancer.
Flentje M; Huber RM; Engel-Riedel W; Andreas S; Kollmeier J; Staar S; Dickgreber N; Vaissiere N; De Almeida C; Edlich B; Fietkau R
Strahlenther Onkol; 2016 Apr; 192(4):216-22. PubMed ID: 26809652
[TBL] [Abstract][Full Text] [Related]
20. Dose-escalation study of three-dimensional conformal thoracic radiotherapy with concurrent S-1 and cisplatin for inoperable stage III non-small-cell lung cancer.
Harada H; Nishio M; Murakami H; Ohyanagi F; Kozuka T; Ishikura S; Naito T; Kaira K; Takahashi T; Horiike A; Nishimura T; Yamamoto N
Clin Lung Cancer; 2013 Jul; 14(4):440-5. PubMed ID: 23540866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
